Envisioning 2.0

As readers of this blog are aware, my firm, Envision Solutions, recently published a report focusing on Americans’ views of pharmaceutical industry support of non-profits. Shortly after it appeared, Eli Lilly and Company announced that it would fully disclose grants it awarded to US based non-profits for continuing medical education and other purposes. I think Eli Lilly’s move is a good one, as I observed last month in PR Week.

Now, a coalition of advocacy organizations, including Public Citizen, has released a letter urging pharmaceutical companies to “disclose industry funding to charitable and educational organizations” on a global basis. News reports indicate that some companies are thinking about disclosing this information, but will need to think about the policy, financial and communications implications of such a move.

As I’ve said before, non-profits and pharma companies should be looking for ways to proactively communicate about their cause alliances. For those interested in getting ahead of this issue, Envision Solutions’ report offers some guidance. To learn more about it, please click here.

Source: Pharmalot

This entry was posted on June 11, 2007 at 12:27 pm and is filed under The Pharmaceutical Industry. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.